A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis.
Lenglet T, Lacomblez L, Abitbol JL, Ludolph A, Mora JS, Robberecht W, Shaw PJ, Pruss RM, Cuvier V, Meininger V; Mitotarget study group.
Lenglet T, et al.
Eur J Neurol. 2014 Mar;21(3):529-36. doi: 10.1111/ene.12344. Epub 2014 Jan 21.
Eur J Neurol. 2014.
PMID: 24447620
Clinical Trial.